Fair Value Measurement Roll Forward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent Earn-out Liability	$ 0	$ 5,491	$ 25,572	$ 2,589
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances			55,158
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	(5,399)	(16,247)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3		(3,379)
Currency translation on earn-out	$ (92)	41	(84)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Change in fair value of contingent earn-out
Fair value measurements with unobservable inputs reconciliation, other		(496)
Pursuit Vascular, Inc. [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)			$ (32,091)
Smiths Medical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent earn-out liability, Noncurrent		53,500
Foreign Infusion System Supplier
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Contingent earn-out liability, Noncurrent		$ 1,600